• Info
  • Insider Ownership

Insider Trading & Ownership of Frank Torti

Location
Menlo Park, CA
Summary
The estimated net worth of Frank Torti is at least $319,679,028 dollars as of 09 Apr 2026. Frank Torti is the President and Vant Chair of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $294.61M. Frank Torti is the Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $25.07M.
Signature
/s/ Tiago Girao, attorney-in-fact for Frank Torti
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Frank Torti and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Frank Torti has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $319,679,028.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Roivant Sciences Ltd. ($294,610,310).
  • Past-year value change for that position: -$82,039,460.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Frank Torti

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. President and Vant Chair $294,610,310 -$82,039,460 -22% 31 Mar 2026
IMVT Immunovant, Inc. Director $25,068,718 07 Apr 2026
ABUS Arbutus Biopharma Corp Director 23 May 2024

Insider Transactions Reported by Frank Torti:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.